INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
20/04/2026
Voltar para busca
Dado oficial do USPTO
DBV TECHNOLOGIES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
21/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 42, 44
Data de depósito
06/11/2018
Data de registro
23/07/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/08/2025
Última transação
21/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
707
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
98
Localização do titular
Châtillon, FR
Examinador
RIEPEL, CHRISTINA MAXINE
Localização atual
Historical data usage
Descrição da marca
The mark consists of the wording a "DBV TECHNOLOGIES" in black and a design comprised of two gray concentric circles above a cyan curved line. White is not claimed as a feature of the mark and represents background or transparent areas, only.
Titulares e representantes
Titulares
D. T. (pessoa física)
D. T. (pessoa física)
Representantes
Anthony E. Bennett Hoffmann & Baron, LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
adhesive patches enabling cutaneous or epicutaneous administration of powdered medicated or pharmaceutical substances for humans or animals featuring pharmaceutical preparations for treatment of allergiesinflammatory and autoimmune diseases; drug delivery patch containing a preparation in powder form for medical use for the treatment of allergiesinflammatory and autoimmune diseases; medicated occlusive patch enabling the cutaneous absorption of a powdered medicated substance featuring pharmaceutical preparations for treatment of allergiesinflammatory and autoimmune diseases
Classe 10
medical apparatusinstruments and devices for the cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for humans or animalsdrug delivery patches sold without medication; occlusive dispenser for medical use sold without medication; medical instrument using electrostatic properties from a biocompatible supportnamely epicutaneous patches sold without medication
Classe 42
research in the field of immunotherapy; design of a scientific method for epicutaneous desensitization via immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; scientific research in the field of processing and treatment of allergies; scientific research in the field of allergy treatment for a treatment to be applied repeatedly to the skin of the patient without prior preparation of the skinother than simple and light cleaning in order to leave the cell structure of the skin intactthus avoiding the transfer of the allergen into the blood; drug discovery being scientific research and development of allergens; design of methods for the treatment of allergy-causing by the combination of immune cells from the skin; design of methods for treating allergies via the application of a patch to the unbroken skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact
Classe 44
medical services applying a method for desensitizing by immunotherapy; medical treatment of allergiesinflammatory and autoimmune diseases via allergen administration by placing a patch on the patient's intact skin while preventing the allergen from getting into the blood; medical treatment of allergiesinflammatory and autoimmune diseases using a method for desensitizing by epicutaneous immunotherapy; medical treatment of allergiesinflammatory and autoimmune diseases by epicutaneous immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; medical consultancy in the field of desensitization to combat allergies
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
20/08/2025
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
20/08/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
20/08/2025
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
20/08/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/08/2025
ES71
TEAS SECTION 71 RECEIVED
22/07/2025
E15R
TEAS SECTION 15 RECEIVED
22/07/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/09/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
16/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/09/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/09/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/09/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
23/07/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
13/07/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/06/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/11/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/12/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
15/11/2019
FIMP
FINAL DISPOSITION PROCESSED
15/11/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/10/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
23/07/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/05/2019
PUBO
PUBLISHED FOR OPPOSITION
07/05/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/04/2019
RFNT
REFUSAL PROCESSED BY IB
16/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/03/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/03/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/02/2019
RFRR
REFUSAL PROCESSED BY MPU
28/02/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/02/2019
CNRT
NON-FINAL ACTION WRITTEN
19/02/2019
MAFR
APPLICATION FILING RECEIPT MAILED
15/02/2019
DOCK
ASSIGNED TO EXAMINER
11/02/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/02/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/02/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DBV TECHNOLOGIES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.